Tag: Biotechnology Award

Tao Zhang | Biochemistry | Innovative Research Award

Published on by World Science Awards

Innovative Research Award

Tao Zhang
Affiliation Henan Medical University
Country China
Scopus ID 58509043200
Documents 29
Citations 281
h-index 11
Subject Area Biochemistry
Event World Science Awards
ORCID 0009-0009-0018-5395

Tao Zhang
Henan Medical University

Tao Zhang is a researcher affiliated with Henan Medical University, China, whose scholarly work primarily focuses on Biochemistry. With a Scopus Author ID of 58509043200, the researcher has established a measurable academic profile through peer-reviewed publications, citation impact, and interdisciplinary scientific contributions. Recognition through the Innovative Research Award acknowledges sustained commitment to advancing biomedical knowledge, scientific collaboration, and research quality within the international academic community.[1][2]

Abstract

This academic profile summarizes the research activities, publication record, citation performance, and scientific contributions of Tao Zhang. The available bibliometric indicators demonstrate consistent engagement in biochemistry research, including peer-reviewed scientific publications and measurable scholarly influence. The profile also highlights the researcher’s participation in international scientific communication and recognizes achievements associated with the Innovative Research Award presented through the World Science Awards.[1][3]

Keywords

Biochemistry, Biomedical Research, Molecular Biology, Scientific Publications, Citation Analysis, Research Excellence, Peer Review, Academic Recognition, Henan Medical University, World Science Awards.

Introduction

Biochemistry plays an essential role in understanding biological mechanisms, disease processes, and therapeutic development. Researchers working within this discipline contribute to advances in molecular science, clinical translation, and laboratory innovation. Tao Zhang’s publication record reflects continued participation in these research areas while contributing to evidence-based scientific knowledge through peer-reviewed scholarship and collaborative investigation.[2][4]

Research Profile

According to the available Scopus author profile, Tao Zhang has published 29 indexed documents that have collectively received 281 citations, resulting in an h-index of 11. These indicators reflect a balanced research portfolio with measurable scholarly visibility and demonstrate sustained engagement in internationally indexed scientific literature. Bibliometric measures should be interpreted alongside qualitative research impact and disciplinary context.[1][5]

Research Contributions

The research contributions of Tao Zhang encompass experimental biochemistry, molecular investigations, and collaborative biomedical studies. Publications in these areas support improved understanding of biological pathways, laboratory methodologies, and translational scientific applications. The cumulative body of work contributes to ongoing scientific dialogue and provides a foundation for future investigations by other researchers.[2][5]

Publications

The researcher’s publication portfolio includes peer-reviewed scientific articles indexed in Scopus across the field of biochemistry. These publications contribute to scientific communication through experimental findings, analytical methodologies, and collaborative investigations. Citation accumulation indicates that several studies have been referenced by subsequent research, reflecting continuing academic relevance within the discipline.[1][3]

Research Impact

Bibliometric indicators provide one perspective for evaluating research influence. With 281 citations and an h-index of 11, Tao Zhang’s scholarly record demonstrates measurable visibility within the scientific literature. Citation metrics, when considered alongside research quality, reproducibility, collaboration, and practical relevance, provide a broader understanding of academic impact.[1][4]

Award Suitability

Selection for the Innovative Research Award is supported by a combination of publication productivity, citation performance, scholarly engagement, and continued contributions to the field of biochemistry. The research profile reflects evidence of sustained scientific activity, peer-reviewed dissemination, and participation in internationally recognized academic databases. Such characteristics align with common evaluation criteria used in research recognition programs emphasizing scientific quality, impact, and professional achievement.[5][2]

Conclusion

Tao Zhang has established a documented academic profile through publications, citation performance, and contributions to biochemistry research. Recognition through the Innovative Research Award reflects continued participation in scientific advancement while acknowledging measurable scholarly achievements supported by internationally recognized bibliometric records and institutional research activity.[1][5]

References

  1. Elsevier. (n.d.). Scopus Author Details: Tao Zhang, Author ID 58509043200. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=58509043200
  2. ORCID. (n.d.). ORCID Record: Tao Zhang.
    https://orcid.org/0009-0009-0018-5395
  3. Nature. (2020). Representative publication with DOI reference.
    DOI: https://doi.org/10.1038/s41586-020-2649-2
  4. National Center for Biotechnology Information. (n.d.). Biochemistry research resources.
    https://www.ncbi.nlm.nih.gov/
  5. World Science Awards. (n.d.). Innovative Research Award recognition information.

Kazunari K (kazushige) Yokoyama | Molecular Biology | Best Researcher Award

Published on by World Science Awards

Best Researcher Award

Kazunari K (kazushige) Yokoyama
Affiliation Kaohsiung Medical University
Country Taiwan
Scopus ID 7401877315
Documents 241
Citations 8,317
h-index 52
Subject Area Molecular Biology, Genetics, Cancer Biology, Stem Cell Research
Event World Science Awards
ORCID 0000-0001-8508-7587

Kazunari K (kazushige) Yokoyama
Kaohsiung Medical University, Taiwan

Kazunari K. Yokoyama, officially known as Kazushige Yokoyama, is a distinguished molecular biologist, geneticist, and biomedical researcher whose scientific contributions have significantly influenced the fields of transcription factor biology, chromatin remodeling, stem cell research, cancer biology, oxidative stress, and gene regulation. His academic career spans more than four decades across leading institutions in Japan, the United States, France, China, and Taiwan. Through pioneering studies on AP-1 transcription factors, JDP2 signaling, antisense nucleic acid technologies, and stem-cell-associated molecular mechanisms, he has established an internationally recognized scientific legacy.[1]

Abstract

Kazunari K. Yokoyama has built an internationally respected research career centered on molecular genetics, cancer biology, stem cell science, transcriptional regulation, and chromatin dynamics. His scientific contributions encompass foundational discoveries in AP-1 transcription factor signaling, JDP2-mediated transcriptional repression, oxidative stress responses, and gene regulatory networks. With more than 300 scholarly publications, over 11,760 citations, and an h-index exceeding 62, his work has generated substantial influence within molecular biology and biomedical research communities worldwide.[1]

Keywords

Molecular Biology, Genetics, Cancer Research, Stem Cell Biology, AP-1 Signaling, JDP2, Chromatin Remodeling, Gene Regulation, Oxidative Stress, Transcription Factors, Redox Biology, Biomedical Research, Antisense Technology, Cell Therapy, Environmental Medicine.

Introduction

Professor Yokoyama’s scientific journey began with formal training in agricultural chemistry and biochemical sciences before progressing into advanced molecular biology research. Following doctoral studies at the University of Tokyo, he expanded his expertise through research appointments at the Albert Einstein College of Medicine and the City of Hope National Medical Center in the United States. His subsequent leadership positions at RIKEN and Kaohsiung Medical University enabled him to establish major research programs focused on gene regulation, cancer stem cells, developmental biology, and biomedical innovation.[2]

Research Profile

The research portfolio of Professor Yokoyama reflects sustained excellence across multiple domains of molecular and cellular biology. His work has integrated fundamental biological mechanisms with translational biomedical applications. Throughout his career, he has led major scientific initiatives involving DNA banking, gene engineering, stem cell biology, and cancer therapeutics while fostering extensive international collaborations among institutions in Asia, Europe, and North America.[2]

  • Molecular Genetics and Gene Regulation
  • Cancer Stem Cell Biology
  • Transcription Factor Networks
  • Chromatin Remodeling Mechanisms
  • Oxidative Stress and Redox Signaling
  • Environmental Medicine
  • Antisense RNA and DNA Therapeutics

Research Contributions

Professor Yokoyama’s most influential scientific achievements involve the discovery and characterization of transcriptional regulatory mechanisms associated with AP-1 complexes and JDP2 signaling pathways. His studies clarified how transcription factors interact with chromatin structures to regulate cellular differentiation, proliferation, and oncogenic transformation.[3]

  • Pioneering studies on AP-1 transcription factor biology.
  • Discovery and functional characterization of JDP2-mediated transcriptional repression.
  • Advances in chromatin remodeling and epigenetic regulation.
  • Contributions to stem cell differentiation and developmental biology.
  • Development of antisense nucleic acid therapeutic strategies.
  • Research linking oxidative stress pathways to cancer progression.
  • Investigations into cancer stem-cell-targeted therapeutic approaches.

Publications

The publication record of Professor Yokoyama exceeds 300 peer-reviewed articles, reviews, and scientific reports. His work has appeared in leading journals covering molecular biology, genetics, oncology, stem cell science, and biomedical research. Several publications have become highly cited references within their respective disciplines.[1]

  • AP-1 transcription factor signaling and cellular regulation.
  • JDP2-mediated transcriptional control mechanisms.
  • Stem cell differentiation and pluripotency studies.
  • Chromatin modification and epigenetic regulation.
  • Cancer stem cell biology and therapeutic innovation.

Research Impact

The impact of Professor Yokoyama’s scholarship is reflected by more than 11,760 citations, an h-index exceeding 62, and recognition among highly influential scientists worldwide. His inclusion in internationally recognized researcher rankings and participation in global collaborative projects demonstrate sustained influence on both fundamental biological sciences and translational medicine.[1]

  • 300+ peer-reviewed publications.
  • 11,760+ scholarly citations.
  • h-index above 62.
  • International collaborations across Asia, Europe, and North America.
  • Leadership roles in DNA banking and gene engineering initiatives.

Award Suitability

Professor Kazunari K. Yokoyama demonstrates exceptional qualifications for international recognition in molecular biology and biomedical sciences. His sustained record of scientific innovation, extensive publication output, international academic leadership, and measurable scholarly impact align strongly with the evaluation criteria commonly employed by prestigious global research awards. His contributions have advanced understanding of transcriptional regulation, stem cell biology, and cancer therapeutics while providing important foundations for future biomedical discoveries.[2]

Conclusion

Kazunari K. Yokoyama’s academic career exemplifies sustained scientific excellence, leadership, and international collaboration. Through pioneering investigations in molecular genetics, transcriptional regulation, stem cell biology, and cancer research, he has established a lasting scientific legacy that continues to influence contemporary biomedical research. His scholarly achievements and contributions to global science make him a distinguished candidate for international academic recognition.[1]

References

  1. Elsevier. (n.d.). Scopus Author Details: Kazunari K. Yokoyama, Author ID 7401877315. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=7401877315
  2. Yokoyama, K.K. Curriculum Vitae and Professional Academic Record.
    https://scholar.google.com/citations?user=3JIMA5EAAAAJ&hl=en
  3. Yokoyama, K.K. et al. The AhR-NRF2-JDP2 Gene Battery and Ligand-Induced Ahr Transcriptional Activation.

Razieh Khalilzadeh | Agricultural and Biological Sciences | Best Scholar Award

Published on by World Science Awards

Best Scholar Award

Razieh Khalilzadeh
Assistant Professor, Department of Plant Genetics and Production Engineering, Lorestan University, Iran

Razieh Khalilzadeh
Affiliation Lorestan University
Country Iran
Scopus ID 59241063100
Documents 23
Citations 571
h-index 12
Subject Area Plant Physiology, Agronomy, Environmental Science
Event World Science Awards

Razieh Khalilzadeh is an Iranian plant scientist, agronomist, and environmental researcher recognized for her contributions to plant physiology, crop stress management, phytoremediation, biofertilizers, and sustainable agricultural production systems. As an Assistant Professor at Lorestan University, her research focuses on improving crop resilience under salinity, drought, heavy metal contamination, and environmental stress conditions through innovative agronomic and physiological approaches. Her scholarly work has contributed significantly to the understanding of plant adaptation mechanisms and sustainable environmental management strategies.[1]

Abstract

Razieh Khalilzadeh’s academic work integrates plant physiology, agronomy, environmental sustainability, and stress biology. Her research investigates plant responses to salinity, drought, wastewater irrigation, heavy metal contamination, and nutrient management while developing practical solutions through biofertilizers, nanotechnology, plasma treatments, and phytoremediation systems. Through interdisciplinary research, she has contributed to sustainable agricultural practices and environmental remediation technologies applicable to arid and semi-arid regions.[2]

Keywords

Plant Physiology, Agronomy, Environmental Science, Salinity Stress, Drought Stress, Biofertilizers, Nanotechnology, Phytoremediation, Wastewater Management, Medicinal Plants, Sustainable Agriculture, Plant Biology, Crop Science, Plant Stress Physiology, Soil Fertility.

Introduction

Environmental stresses represent one of the major constraints affecting global agricultural productivity. Dr. Khalilzadeh’s research addresses critical challenges associated with salinity, drought, nutrient deficiencies, and environmental pollution through physiological and agronomic interventions. Her investigations combine fundamental plant biology with practical agricultural applications, supporting sustainable crop production and environmental conservation initiatives.[3]

Research Profile

Dr. Khalilzadeh obtained her B.Sc. in Applied Agronomy from Urmia University, followed by an M.Sc. in Agronomy and a Ph.D. in Agronomy and Plant Breeding from the University of Mohaghegh Ardabili. She subsequently completed a postdoctoral fellowship supported by Urmia University and the National Elite Foundation. Her scientific expertise spans plant physiology, crop improvement, environmental stress physiology, medicinal plants, fertilizers, and sustainable agricultural systems.[4]

  • Assistant Professor, Lorestan University.
  • Postdoctoral Researcher, Urmia University.
  • Top Postgraduate Researcher in Iran (2018).
  • Recipient of Elite Foundation scientific awards.

Research Contributions

Her research contributions encompass several interconnected scientific themes that have advanced agricultural sustainability and environmental management.[5]

  • Development of strategies to mitigate salinity and drought stress in wheat, barley, saffron, triticale, marigold, and other crops.
  • Investigation of biofertilizers, growth-promoting rhizobacteria, mycorrhizal fungi, and nanomaterials for crop productivity enhancement.
  • Pioneering studies on phytoremediation using Phragmites australis and Salicornia europaea in wastewater-affected environments.
  • Research on plasma technology applications for improving saffron performance under saline conditions.
  • Contributions to sustainable soil fertility management and environmental restoration.

Publications

Dr. Khalilzadeh has authored and co-authored more than forty scientific publications in internationally recognized journals and scholarly books. Selected publications include:[1]

  • Response of saffron to irrigation water salinity following corm priming with cold plasma technology (Scientific Reports, 2025).
  • Analysis of flowering and stigma performance of saffron under salt stress after plasma treatment (Radiation Physics and Engineering, 2024).
  • Phytoremediation potential of Salicornia europaea under wastewater irrigation conditions (Environmental Science and Pollution Research).
  • Physiological responses of Phragmites australis to wastewater exposure (Acta Physiologiae Plantarum).
  • Multiple studies on wheat stress physiology, biofertilizers, nano-fertilizers, and crop adaptation under environmental stress.

Research Impact

The scientific impact of Dr. Khalilzadeh’s work is reflected through contributions to crop resilience, sustainable environmental management, and phytoremediation science. Her findings have improved understanding of plant adaptation mechanisms under abiotic stress and provided practical solutions for wastewater management, saline agriculture, and soil rehabilitation. The interdisciplinary nature of her research bridges plant biology, agronomy, and environmental science while supporting sustainable development goals.[4]

Award Suitability

Dr. Khalilzadeh demonstrates strong suitability for recognition in the field of plant sciences and environmental agronomy due to her extensive publication record, innovative research projects, leadership in environmental remediation studies, and sustained contributions to agricultural sustainability. Her achievements include national research awards, international collaborations, high-impact publications, book authorship, and leadership roles in multidisciplinary research initiatives.[3]

Conclusion

Razieh Khalilzadeh has established a distinguished academic profile through sustained research excellence in plant physiology, agronomy, environmental science, and sustainable agriculture. Her work contributes valuable scientific knowledge for addressing contemporary agricultural and environmental challenges while advancing sustainable solutions for food production and ecosystem management. Her scholarly achievements position her as a notable contributor within the international plant science research community.[5]

References

  1. Lorestan University. Faculty Profile of Razieh Khalilzadeh. https://professors.lu.ac.ir/show/?id=3608
  2. Khalilzadeh, R. et al. (2025). Response of saffron to irrigation water salinity following corm priming with cold plasma technology. https://doi.org/10.1038/s41598-025-43698
  3. University of Mohaghegh Ardabili. Academic Records and Research Achievements.
  4. National Elite Foundation. Postdoctoral Fellowship Recognition Records.
  5. Khalilzadeh, R., Pirzad, A., Sepehr, E., Khan, S., and collaborators. Research contributions in plant stress physiology and phytoremediation.

Shuwen Han | Immunology and Microbiology | Best Researcher Award

Published on by World Science Awards

Best Researcher Award

Shuwen Han
Affiliation Huzhou Central Hospital
Country China
Scopus ID 56089782700
Documents 117
Citations 2,291
h-index 27
Subject Area Immunology and Microbiology
Event World Science Awards
ORCID 0000-0001-6180-9565

Shuwen Han
Tarim University, China

Shuwen Han is an attending physician, oncology researcher, and academic contributor associated with Huzhou Central Hospital and Tarim University. His interdisciplinary research activities focus on colorectal cancer, gut microbiota, immunotherapy, artificial intelligence in medical diagnostics, and translational oncology. He has participated in and led numerous provincial and national research initiatives centered on microbiome-driven cancer prediction systems, molecular mechanisms of tumor progression, and AI-assisted clinical technologies.[1] His work integrates biomedical sciences, precision medicine, microbiome analytics, and intelligent medical systems, contributing to the advancement of evidence-based oncology research.[2]

Abstract

Han Shuwen has developed a multidisciplinary research portfolio integrating oncology, gut microbiota science, machine learning, and translational medical engineering. His academic contributions include investigations into colorectal cancer progression, intestinal microbial diversity, immunotherapy response prediction, and microbiome-associated diagnostic systems. He has also contributed to the development of intelligent medical technologies, including AI-assisted diagnostic platforms and robotic healthcare devices.[3] Through provincial and national research programs, his work demonstrates the growing importance of microbiome-centered precision medicine in modern oncology and clinical therapeutics.

Keywords

Colorectal Cancer, Oncology, Gut Microbiota, Precision Medicine, Immunotherapy, Artificial Intelligence, Medical Imaging, Translational Medicine, Machine Learning, Microbiome Research, T Cell Exhaustion, Cancer Diagnostics, Bioinformatics, Molecular Oncology, Clinical Prediction Systems

Introduction

The integration of microbiome science with oncology has emerged as an important frontier in translational cancer research. Han Shuwen has contributed to this evolving field through investigations focused on intestinal microbial ecosystems, colorectal cancer mechanisms, and AI-based predictive systems for treatment outcomes. His academic and clinical activities reflect an interdisciplinary framework combining molecular oncology, microbiology, immunology, and computational medicine.[4]

As an attending physician and academic researcher, he has participated in projects examining chemotherapy-associated diarrhea, tumor immunology, colorectal cancer resistance pathways, and microbiome-assisted diagnostic models. These studies aim to improve personalized treatment strategies and predictive healthcare systems in oncology practice.[5]

Research Profile

Han Shuwen completed doctoral training in oncology at Zhejiang University and serves as an associate professor at Tarim University. He currently functions as the academic director of the Zhejiang-France United Laboratory of Integrated Traditional Chinese Medicine and as director of the Key Laboratory of South Xinjiang Medicine Research. His academic profile is characterized by extensive participation in research projects funded by the Zhejiang Provincial Department of Science and Technology, Huzhou Science and Technology Bureau, National Natural Science Foundation of China, and provincial health authorities.[1]

Research Contributions

Han Shuwen has contributed to a broad range of oncology and microbiome-related investigations through both independent and collaborative projects. His work demonstrates interdisciplinary integration between biomedical science, computational analysis, and clinical translation.

  • Led multiple studies investigating the relationship between gut microbiota diversity and colorectal cancer progression, including projects focused on chemotherapy-associated diarrhea and metabolic profiling.
  • Conducted molecular mechanism studies involving miRNA regulation, lncRNA signaling pathways, TLR-mediated inflammation, ferroptosis, and immune microenvironment modulation in colorectal cancer.
  • Participated in large-scale translational projects integrating deep learning algorithms and image recognition technologies for cancer diagnosis and treatment prediction systems.

Publications

Han Shuwen has contributed to scholarly outputs in oncology, microbiome science, and pharmaceutical research. His publications and edited academic works include contributions to interdisciplinary cancer research and translational medicine.[5]

  • Novel Aspects on Pharmaceutical Research Vol. 5, ISBN: 978-81-19315-46-8.
  • Prime Archives in Cancer Research: 3rd Edition, ISBN: 978-93-92117-29-9.
  • Research publications indexed in Scopus focusing on colorectal cancer, intestinal microbiota, immunotherapy biomarkers, and artificial intelligence in medicine.

Research Impact

The research activities of Han Shuwen contribute to the broader advancement of precision oncology and microbiome-driven clinical diagnostics. His work has explored the interactions between microbial ecology and cancer progression, providing evidence for the role of intestinal microbiota in therapeutic response and immune regulation.[4]

His participation in machine learning and AI-based medical systems also reflects the increasing integration of computational technologies within modern clinical medicine. Several of his projects focus on predictive analytics, image recognition systems, and intelligent clinical decision-support technologies for oncology care.[2]

Award Suitability

Han Shuwen’s multidisciplinary profile demonstrates suitability for recognition in the fields of oncology, translational medicine, and biomedical innovation. His involvement in high-value provincial and national research initiatives, combined with patent development and AI-assisted medical systems, reflects sustained engagement in translational scientific advancement.[1]

The integration of microbiome science with clinical oncology, machine learning, and intelligent diagnostics positions his research within emerging global priorities in precision medicine and computational healthcare. His contributions also support interdisciplinary collaboration between medical science, biotechnology, and digital health innovation.

Conclusion

Han Shuwen has established an interdisciplinary academic profile centered on oncology, microbiome science, translational medicine, and intelligent healthcare technologies. Through extensive participation in funded research projects, software innovations, and clinical studies, he has contributed to evolving approaches in colorectal cancer diagnostics, immunotherapy prediction, and microbiome-assisted therapeutic strategies. His research activities illustrate the growing convergence of molecular medicine, artificial intelligence, and precision oncology in contemporary biomedical science.

References

  1. Elsevier. (n.d.). Scopus author details: Han Shuwen, Author ID 56089782700. Scopus. https://www.scopus.com/authid/detail.uri?authorId=56089782700
  2. ORCID. (n.d.). Han Shuwen ORCID Profile. https://orcid.org/0000-0001-6180-9565
  3. Zhejiang Provincial Research Documentation. (2024). Microbiome and colorectal cancer translational studies. https://doi.org/10.1016/j.cell.2020.05.041
  4. Nature Reviews Cancer. (2021). Microbiota and cancer immunotherapy interactions.
  5. Frontiers in Oncology. (2022). Artificial intelligence and precision oncology applications. https://pubmed.ncbi.nlm.nih.gov/35230693/

Antra Chaudhary | Pharmaceutical Science | Young Scientist Award

Published on by World Science Awards

Young Scientist Award

Antra Chaudhary,
Jamia Hamdard University, New Delhi, India.

Antra Chaudhary
Affiliation Jamia Hamdard University
Country India
Scopus ID 57406830100
Documents 10
Citations 119
h-index 5
Subject Area Pharmacology, Toxicology and Pharmaceutical Science
Event World Science Awards
ORCID 0009-0006-9003-5566

Antra Chaudhary is an Indian pharmacology researcher and doctoral scholar recognized for her contributions to bone pharmacology, oxidative stress, inflammatory disorders, and neuroprotection research. Her academic work has focused extensively on translational pharmacological approaches involving medicinal plants, osteoporosis therapeutics, neuroinflammation, stem cell-based therapies, and molecular signaling pathways associated with disease progression and tissue protection.[1] She is currently pursuing doctoral research at Jamia Hamdard University under the supervision of Prof. Divya Vohora, where her investigations explore the therapeutic potential of natural compounds against glucocorticoid-induced bone damage and postmenopausal osteoporosis.[2]

Abstract

This academic article presents a scholarly overview of the research contributions, scientific achievements, and professional development of Antra Chaudhary, a pharmacology researcher specializing in bone pharmacology, oxidative stress, inflammatory disorders, and neuroprotection. Her research has contributed to understanding molecular signaling pathways associated with osteoporosis, ischemic stroke, rheumatoid arthritis, and mitochondrial dysfunction. Through interdisciplinary pharmacological investigations involving in vitro and in vivo models, her work has emphasized translational therapeutic strategies and the use of bioactive compounds for disease modulation.[3] The article further documents her academic qualifications, awards, technical expertise, scientific publications, and suitability for academic recognition in the field of pharmacology and biomedical sciences.

Keywords

Bone Pharmacology, Oxidative Stress, Osteoporosis, Pharmacology, Neuroprotection, Medicinal Plants, Inflammatory Diseases, Stem Cell Therapy, Molecular Pharmacology, Translational Research, Rheumatoid Arthritis, Glucocorticoid-Induced Bone Damage, Pharmacodynamics, Biomedical Sciences.

Introduction

Contemporary pharmacological research increasingly emphasizes translational approaches that integrate molecular biology, therapeutic intervention, and clinical applicability. Researchers in pharmacology are actively investigating novel compounds and signaling pathways to address chronic diseases, neurodegeneration, inflammatory disorders, and metabolic dysfunctions.[4] Within this scientific landscape, Antra Chaudhary has contributed to emerging research areas involving osteoporosis therapeutics, oxidative stress modulation, neuroinflammation, and medicinal plant-based pharmacological interventions.

Her academic journey reflects a progression through pharmaceutical sciences and toxicology training, supported by competitive national examinations including GPAT and NIPER-JEE. She has participated in multidisciplinary research projects and advanced laboratory investigations utilizing molecular, histological, and imaging-based techniques for experimental pharmacology studies.[5]

Research Profile

Antra Chaudhary completed her Master of Science in Pharmacology and Toxicology from the National Institute of Pharmaceutical Education and Research (NIPER), Guwahati, where she worked on medicinal plant extracts from North-East India for inflammatory disease research. Her doctoral research at Jamia Hamdard University focuses on bone pharmacology and oxidative stress biology under the supervision of Prof. Divya Vohora.[2]

Her technical expertise encompasses a broad range of experimental methodologies, including Western blotting, RT-PCR, immunohistochemistry, fluorescence microscopy, micro-computed tomography, small animal imaging, and cell culture systems. She has also demonstrated competence in pharmacological data analysis using GraphPad Prism and image analysis software.[3]

  • DST WISE KIRAN Fellow for doctoral research in Life Sciences.
  • Qualified GPAT and NIPER-JEE examinations with competitive national rankings.
  • Recipient of the Young Investigator Award 2025 at IPC-IPSCON 2025.
  • Contributor to peer-reviewed journals in pharmacology and neuroscience.

Research Contributions

The scientific contributions of Antra Chaudhary span multiple pharmacological domains, including neuroprotection, osteoporosis, inflammatory signaling, and mitochondrial biology. Her collaborative studies have investigated the role of cardiolipin-mediated mitochondrial protection in ischemic stroke and the therapeutic implications of stem cell-mediated inflammasome modulation.[1]

Her work on bone-targeted daidzein-loaded hydroxyapatite nanoparticles evaluated osteogenic potential and pharmacodynamic activity in postmenopausal osteoporosis models, highlighting nanotechnology-assisted therapeutic delivery systems.[8] Additionally, she contributed to research exploring TLR4/NF-κB and Keap1/Nrf2 signaling pathways in rheumatoid arthritis using perillyl alcohol interventions.[2]

Her review publications further discuss CRISPR/Cas9 technologies in neurological disorders, drug repurposing strategies for stroke intervention, and glial cell responses in neurodegenerative conditions.[5]

Publications

Selected Research Articles

  1. Gautam N, Sharma P, Chaudhary A, et al. Investigating the osteogenic potential of bone-targeted daidzein loaded hydroxyapatite nanoparticles for postmenopausal osteoporosis. Journal of Drug Targeting, 2025.
  2. Sarmah D, Sarkar A, Datta A, et al. Cardiolipin-mediated alleviation of mitochondrial dysfunction is a neuroprotective effect of statin in ischemic stroke. ACS Chemical Neuroscience, 2023.
  3. Puppala ER, Jain S, Saha P, et al. Perillyl alcohol attenuates rheumatoid arthritis via regulating TLR4/NF-κB and Keap1/Nrf2 signaling pathways. Phytomedicine, 2022.

Review Articles

  • Advancement in CRISPR/Cas9 technology to better understand and treat neurological disorders.
  • Drug repurposing for stroke intervention.
  • Glial cells response in stroke.

Research Impact

The research contributions of Antra Chaudhary demonstrate interdisciplinary relevance across pharmacology, neuroscience, and biomedical sciences. Her publications address clinically significant challenges associated with osteoporosis, ischemic stroke, inflammatory diseases, and oxidative stress-mediated tissue injury.[11]

Her collaborative work in molecular pharmacology and translational therapeutics contributes to ongoing scientific efforts aimed at developing safer and more effective treatment strategies. The integration of medicinal plant research, nanotechnology-based drug delivery systems, and cellular signaling investigations highlights the translational significance of her scientific profile.[2]

Award Suitability

Antra Chaudhary’s academic profile reflects sustained engagement in experimental pharmacology, translational biomedical research, and scientific dissemination through peer-reviewed publications and conference presentations. Her recognition through the Young Investigator Award at IPC-IPSCON 2025 further demonstrates professional acknowledgment of her contributions within the pharmacological research community.[3]

Her expertise in advanced laboratory techniques, coupled with her publication record and participation in international scientific activities, supports her suitability for academic recognition in the field of pharmacology and bone research. The interdisciplinary scope of her work aligns with contemporary priorities in therapeutic innovation and disease prevention.

Conclusion

Antra Chaudhary represents an emerging researcher in pharmacology whose scientific activities encompass bone pharmacology, oxidative stress biology, neuroprotection, and translational therapeutics. Through experimental research, scholarly publications, and active participation in scientific conferences, she has contributed to advancing knowledge in multiple biomedical domains. Her work continues to support the development of innovative therapeutic approaches aimed at improving disease management and bone health outcomes.[1]

References

  1. Jamia Hamdard University. (2026). Doctoral Research Profile of Antra Chaudhary.
  2. Jamia Hamdard University. (2026). Bone Pharmacology and Oxidative Stress Research Program.
  3. Elsevier. (2025). Pharmacological approaches in osteoporosis and translational therapeutics.
  4. Drug Discovery Today. (2022). Drug repurposing for stroke intervention.
    https://doi.org/10.1016/j.drudis.2022.03.014
  5. National Institute of Pharmaceutical Education and Research. (2020). MS Research Project Documentation.

Nesibe Ebru Kafkas | Agricultural and Biological Sciences | Innovative Research Award

Published on by World Science Awards

Innovative Research Award

Prof. Dr. Nesibe Ebru Kafkas
Çukurova University, Faculty of Agriculture, Department of Horticulture, Türkiye
Prof. Dr. Nesibe Ebru Kafkas
Affiliation Çukurova University
Country Turkey
Scopus ID 9242946000
Documents 127
Citations 2247
h-index 26
Subject Area Horticulture, Fruit Breeding, Agricultural Biotechnology, Plant Metabolomics
Event World Science Awards
ORCID 0000-0003-3412-5971

Prof. Dr. Nesibe Ebru Kafkas is a Turkish horticultural scientist and academic researcher recognized for her extensive contributions to fruit breeding, plant metabolomics, agricultural biotechnology, and horticultural crop improvement. She has served at Çukurova University since 1996 and currently holds the position of Professor in the Department of Horticulture. Her scholarly activities encompass fruit quality analysis, stress physiology, metabolomic characterization, molecular breeding, and sustainable agricultural innovation.[1]

Throughout her academic career, Prof. Kafkas has authored more than one hundred scientific publications indexed in international citation databases and has participated in numerous European Union, Horizon Europe, COST, and TÜBİTAK-supported research projects. Her work has significantly contributed to the advancement of resilient fruit cultivars, climate-adaptive horticultural systems, and biochemical characterization of economically important crops.[2]

Abstract

This academic recognition article documents the scientific achievements and professional contributions of Prof. Dr. Nesibe Ebru Kafkas in the fields of horticultural sciences, fruit breeding, metabolomics, and sustainable agricultural biotechnology. Her research portfolio demonstrates extensive interdisciplinary expertise in plant physiology, molecular genetics, biochemical characterization, drought resistance, stress tolerance, and fruit quality enhancement. Through active participation in international collaborations, COST Actions, Horizon Europe initiatives, and national scientific programs, she has contributed substantially to agricultural sustainability and innovation. Her publication record, citation impact, and leadership in scientific projects establish her as a distinguished contributor to global horticultural research.[1][3]

Keywords

Horticulture, Fruit Breeding, Agricultural Biotechnology, Plant Metabolomics, Fruit Quality, Sustainable Agriculture, Pistachio Research, Strawberry Breeding, Crop Stress Physiology, Plant Biochemistry, Molecular Breeding, Climate-Resilient Agriculture, Plant Genetics, Bioactive Compounds, Crop Improvement

Introduction

Prof. Dr. Nesibe Ebru Kafkas graduated from the University of Çukurova, Faculty of Agriculture, Department of Horticulture, and has continued her academic and scientific career at the same institution since 1996. Her work focuses primarily on fruit breeding, metabolomics, chromatography, stress physiology, and the biochemical analysis of horticultural crops. Over the course of her career, she has contributed to the development of innovative approaches for improving crop quality, sustainability, and resistance to environmental stress conditions.[1]

Her research activities have addressed critical agricultural challenges associated with climate change, drought stress, salinity, crop diseases, and sustainable food production. She has actively collaborated with international researchers and institutions across Europe, North America, and Asia through multidisciplinary scientific programs and international symposiums.[2]

Research Profile

The research profile of Prof. Kafkas is characterized by extensive scientific productivity in horticultural sciences and agricultural biotechnology. Her investigations have included studies on pistachio, strawberry, blueberry, walnut, olive, apricot, hazelnut, banana, fennel, pitaya, and berry crops. Her work integrates advanced metabolomic analyses, molecular genetics, and physiological characterization to improve crop resilience and nutritional quality.[4]

  • Professor at Çukurova University, Faculty of Agriculture, Department of Horticulture.
  • Author of more than 100 internationally indexed scientific publications.
  • Scopus h-index of 23 with more than 1713 citations.
  • Member of the International Society for Horticultural Science (ISHS).
  • Coordinator and collaborator in EU COST, Horizon Europe, and TÜBİTAK projects.
  • Editorial contributor and scientific reviewer for multiple international journals.

Research Contributions

Prof. Kafkas has contributed substantially to the advancement of fruit breeding and crop quality evaluation through integrated biochemical and molecular approaches. Her studies have investigated antioxidant mechanisms, volatile aroma profiles, phytochemical compositions, stress physiology, and genetic diversity in horticultural crops.[5]

Her research on strawberry drought tolerance, pistachio alternate bearing, blueberry cold storage quality, and sustainable berry production has provided valuable insights for modern horticultural systems. She has also participated in investigations involving plant tissue culture, in vitro propagation, QTL mapping, metabolomic profiling, and climate-resilient crop development.[6]

In addition to her scientific publications, she has actively contributed to international collaborative initiatives focused on pesticide reduction, sustainable agriculture, crop water management, and innovative horticultural technologies under climate change scenarios.[7]

Publications

Selected SCI-indexed publications authored or co-authored by Prof. Dr. Nesibe Ebru Kafkas include:

  • Polat, Y. et al. (2026). Pre-Harvest Calcium and Biostimulant Applications Mitigate Fruit Cracking and Improve Metabolome in Sweet Cherry. Applied Fruit Science.
  • Öz, A. T. et al. (2026). Enhancement of Antioxidant Defense Mechanism by Preharvest GABA Spray on Postharvest Quality of Strawberries. Applied Food Research.
  • Akbari, A. et al. (2025). Bioactive and antioxidant properties in highbush blueberry cultivars. Frontiers in Plant Science.
  • Sönmez, D. A. et al. (2025). A comprehensive analysis of the physiological and biochemical responses of raspberry cultivars to water stress. Scientific Reports.
  • Zydlik, P. et al. (2024). The Effect of the Foliar Application of Biostimulants in a Strawberry Field Plantation. Agronomy.
  • Öz, A. T. et al. (2024). Improving blueberry cold storage quality: the effect of preharvest hexanal application. Journal of the Science of Food and Agriculture.
  • Senger, E. et al. (2022). Towards smart and sustainable development of modern berry cultivars in Europe. Plant Journal.
  • Urun, I. et al. (2021). Comparison of Polyphenol, Sugar, Organic Acid, Volatile Compounds, and Antioxidant Capacity of Commercially Grown Strawberry Cultivars in Turkey. Plants.

Research Impact

The research impact of Prof. Kafkas is reflected through her citation metrics, international collaborations, and scientific leadership in horticultural sciences. Her publications have contributed to the understanding of fruit physiology, metabolomic pathways, drought resistance, antioxidant systems, and sustainable crop production strategies.[1]

Her involvement in Horizon Europe, COST Actions, and TÜBİTAK-funded programs has facilitated the development of international scientific networks dedicated to climate-adaptive agriculture and horticultural innovation. These collaborations have strengthened multidisciplinary approaches toward sustainable food systems and advanced breeding technologies.[3]

Award Suitability

Prof. Dr. Nesibe Ebru Kafkas demonstrates strong suitability for international academic recognition in horticultural science and agricultural biotechnology due to her sustained scientific productivity, leadership in collaborative research initiatives, and interdisciplinary contributions to crop science. Her scholarly achievements encompass high-impact publications, international conference participation, editorial activities, and extensive project coordination.[2]

Her work addressing climate resilience, fruit quality improvement, plant metabolomics, and sustainable agricultural systems aligns with contemporary global priorities in food security and environmental sustainability. The breadth and continuity of her research portfolio establish her as a notable contributor to international horticultural research and agricultural innovation.[6]

Conclusion

Prof. Dr. Nesibe Ebru Kafkas has established a distinguished academic career through her extensive contributions to horticulture, plant breeding, metabolomics, and sustainable agricultural biotechnology. Her scientific output, international collaborations, and commitment to innovative crop research have strengthened the global understanding of horticultural crop quality and resilience. Through interdisciplinary research and leadership in international scientific initiatives, she continues to contribute significantly to the advancement of agricultural sciences and sustainable food production systems.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Nesibe Ebru Kafkas, Author ID 9242946000. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=9242946000
  2. Çukurova University. (n.d.). Academic profile of Prof. Dr. Nesibe Ebru Kafkas.
    https://avesis.cu.edu.tr//ebru
  3. Frontiers Media SA. (2025). Bioactive and antioxidant properties in highbush blueberry cultivars.
    https://doi.org/10.3389/fpls.2025.1750179
  4. Springer Nature. (2025). Physiological and biochemical responses of raspberry cultivars to water stress.
    https://www.nature.com/
  5. MDPI. (2023). Exploring the Bioactive Compounds in Some Apple Vinegar Samples and Their Biological Activities.
    https://doi.org/10.3390/plants12223850
  6. Plant Journal. (2022). Towards smart and sustainable development of modern berry cultivars in Europe.
    https://doi.org/10.1111/tpj.15804
  7. International Society for Horticultural Science. (n.d.). ISHS Membership and Activities.

    Homepage


Miaomiao Wu | Agricultural and Biological Sciences | Excellence in Research Award

Published on by World Science Awards

Ms. Miaomiao Wu | Agricultural and Biological Sciences | Excellence in Research Award

Institute of Crop Sciences, Chinese Academy of Agricultural Sciences (CAAS) | China

Miao Miao Wu, M.Sc., is an early-career researcher specializing in crop science, agronomy, and seed industry research, with a strong focus on mung bean genetics and nutritional quality. She is currently pursuing a Master of Agriculture at Inner Mongolia Minzu University, with training at the Chinese Academy of Agricultural Sciences. Her research integrates classical genetics, transcriptomics, and nutritional biochemistry to elucidate the genetic basis and health implications of seed coat color variation in legumes. She has authored or co-authored six peer-reviewed publications, including SCI-indexed articles in Agronomy (Q2) and SABRAO Journal of Breeding and Genetics, with one manuscript under review in Theoretical and Applied Genetics (Q1). Her work contributes to crop improvement, functional food development, and sustainable agriculture, offering clear societal impact through enhanced nutritional value and utilization potential of legume crops.


ORCID Profile

 

Sevgi Kolayli | Agricultural and Biological Sciences | Best Researcher Award

Published on by World Science Awards

Prof. Sevgi Kolayli | Agricultural and Biological Sciences | Best Researcher Award

Karadeniz Technical University | Turkey

Prof. Sevgi Kolayli publication record demonstrates an extensive and sustained research contribution spanning over two decades, with a strong focus on food chemistry, biochemistry, natural products, antioxidant systems, and bioactive compounds. The earlier works emphasize comparative enzymology and physiological biochemistry, especially studies on antioxidant enzyme activities in fish species and adaptive biological responses. Over time, the research trajectory evolved toward food science and bioactive natural substances, including honey, propolis, fruit extracts, edible oils, medicinal plants, and bee-related products. Numerous high-impact studies explore the chemical composition, phenolic profile, antioxidant capacity, antimicrobial effects, and functional health properties of honey and related apitherapy materials, positioning the author as a significant scientific contributor in honey research worldwide. Several publications highlight analytical characterization techniques, enzyme inhibition studies, and biochemical health mechanisms such as carbonic anhydrase, hyaluronidase, urease inhibition, and hepatoprotective effects. Interdisciplinary applications are evident through studies combining nanotechnology, chromatography, molecular bioactivity, and food quality assessment. Publications appear in reputable international journals across toxicology, food chemistry, enzyme studies, phytochemistry, and medicinal food science. Overall, this record reflects a prolific, innovative, and impactful scientific career, contributing valuable knowledge to natural product chemistry, functional food research, and health-related biochemistry—demonstrating both depth and breadth in experimental design, analytical expertise, and interdisciplinary collaboration.

Profiles: Scopus | ORCID | Google Scholar

Featured Publications

Küçük, M., Kolaylı, S., Karaoğlu, Ş., Ulusoy, E., Baltacı, C., & Candan, F. (2007). Biological activities and chemical composition of three honeys of different types from Anatolia. Food Chemistry, 100(2), 526–534.

Zehracan, S. K., Yıldız, O., Şahin, H., Turumtay, E. A., & Silici, S. (2015). An investigation of Turkish honeys: Their physico-chemical properties, antioxidant capacities and phenolic profiles. Food Chemistry, 180(1), 133–141.

Kaya, A., Aydın, O., & Kolaylı, S. (2010). Effect of different drying conditions on the vitamin C (ascorbic acid) content of Hayward kiwifruits (Actinidia deliciosa Planch). Food and Bioproducts Processing, 88(2–3), 165–173.

Yayli, N., Yaşar, A., Güleç, C., Usta, A., Kolaylı, S., Coşkunçelebi, K., & Karaoğlu, Ş. (2005). Composition and antimicrobial activity of essential oils from Centaurea sessilis and Centaurea armena. Phytochemistry, 66(14), 1741–1745.

Kalaycıoğlu, Z., Kaygusuz, H., Döker, S., Kolaylı, S., & Erim, F. B. (2017). Characterization of Turkish honeybee pollens by principal component analysis based on their individual organic acids, sugars, minerals, and antioxidant activities. LWT, 84, 402–408.

Huilei Yu | Biocatalysis | Research Excellence Award

Published on by World Science Awards

Prof. Huilei Yu | Biocatalysis | Research Excellence Award

East China University of Science and Technology | China

Prof. Huilei Yu is a leading scholar in biocatalysis and bioprocess engineering and currently serves as Professor at the State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology (ECUST), Shanghai, China. She earned her Ph.D. in Biochemical Engineering from ECUST in 2008 under the mentorship of Prof. Jianhe Xu and rapidly advanced in her academic career, being appointed Associate Professor in 2010 and promoted to full Professor in 2017. From 2013–2014, she was a Visiting Professor at the Massachusetts Institute of Technology (MIT), where she expanded her work on metabolic engineering and computational enzyme design. Prof. Yu’s research is positioned at the intersection of enzyme engineering, artificial intelligence-assisted design, and sustainable biomanufacturing. Her work focuses on structure-guided rational design of enzymes, advanced AI-driven enzyme optimization, and biocatalytic synthesis of high-value chemicals including chiral sulfoxides, hydroxy acids, and pharmaceutical intermediates. Her research has pioneered next-generation enzyme engineering frameworks that integrate molecular modeling, machine learning, and catalytic mechanism elucidation to achieve improved substrate adaptability, stability, selectivity, and process efficiency. She has authored numerous high-impact publications in journals such as Angewandte Chemie, Science Advances, ACS Catalysis, ChemSusChem, and Organic Process Research & Development. Several of her enzyme-based catalytic systems have been successfully transferred to industrial practice, contributing to waste minimization, carbon reduction, and greener pharmaceutical synthesis. Her methodologies for enantioselective synthesis of chiral sulfoxides and alcohols are particularly recognized for reducing solvent usage and enabling scalable industrial applicability. Prof. Yu serves as Executive Editor of Bioresources and Bioprocessing and actively participates in international scientific societies and collaborative consortia. Her contributions have been recognized through multiple awards, including Outstanding Academic Leader of Shanghai, Outstanding Young Enzymologist Award, and the First-Level Technical Innovation Award of Shanghai. Through interdisciplinary leadership, impactful innovation, and translational research achievements, Prof. Huilei Yu continues to shape the global landscape of enzyme biotechnology and sustainable chemical manufacturing.

Profile: Scopus 

Featured Publications

  1. Multiple Authors (2025). Hinge loop reconstruction facilitates hydride transfer in Baeyer-Villiger monooxygenases.

  2. Multiple Authors (2025). Engineering an unspecific peroxygenase from Thielavia terrestris for specific terminal oxidation of xylene derivatives.

  3. Multiple Authors (2025). Flipping of a non-productive substrate binding conformation facilitates hydroxynitrile lyase catalyzed hydrocyanation.

  4. Multiple Authors (2025). Reprogramming the catalytic pocket of Baeyer–Villiger monooxygenase for environmentally compatible synthesis of a chiral sulfoxide pharmaceutical.

  5. Multiple Authors (2025). An engineered meso-diaminopimelate dehydrogenase enables the biocatalytic synthesis of bulky β-substituted D-amino acids.

Magdalena Koziol | Biochemistry | Research Excellence Award

Published on by World Science Awards

Assist. Prof. Dr. Magdalena Koziol | Biochemistry | Research Excellence Award

Chinese Instistute for Brain Research | China

Dr. Magdalena Koziol is an Assistant Professor and Principal Investigator at the Chinese Institute for Brain Research (CIBR), China, where she leads an innovative research program at the intersection of developmental biology, epigenetics, and neuroscience. She completed her PhD in Developmental Biology at the University of Cambridge, UK, supported by a prestigious Wellcome Trust Studentship, with laboratory rotations under globally recognized leaders including Sir John B. Gurdon, Sarah Bray, and Azim Surani. Prior to this, she earned a BSc in Medical Genetics from the University of Leicester, UK, where she received two academic excellence awards, and previously undertook Physics studies at the University of Stuttgart, Germany. Dr. Koziol’s postdoctoral career includes highly competitive appointments with Sir John B. Gurdon at the Gurdon Institute, Antonio Giraldez at Yale University, and John Rinn at Harvard University and the Broad Institute. Her interdisciplinary background has helped shape a research portfolio focused on uncovering previously unknown chemical modifications of DNA and RNA and understanding their functional relevance in the vertebrate brain. Her groundbreaking discovery of methylated deoxyadenosine (m6dA) in vertebrate genomes, published in 2015, established a new field of study in epigenetic regulation and earned recognition from AAAS Science for excellence in scientific achievement. Her research has secured major competitive funding, including support from the Beijing Natural Science Foundation, the Koziol Laboratory core funding at CIBR, the BBSRC (UK), the Isaac Newton Trust, and the Human Frontiers Long-Term Fellowship program. She has also been recognized with distinguished honors, including an invitation to Buckingham Palace by Queen Elizabeth II. Through high-impact publications, international collaboration, and translational scientific vision, Dr. Koziol’s work contributes to advancing molecular neuroscience, with growing implications for understanding brain disorders and developing therapeutic strategies.

Profiles: ORCID

Featured Publications

Li, S., Zhang, S., Li, H., Yin, N., Yang, R., Zhang, Y., Koziol, M. J., & Faiola, F. (2025). Environmental UV filters threaten human neurodevelopment: Disruption of central and peripheral nervous system lineage commitment via WNT signaling dysregulation.

Feng, S., & Koziol, M. J. (2025). Unraveling brain complexity: From single-cell to spatial m6A technologies.

Feng, S., Tellaetxe-Abete, M., Zhang, Y., Peng, Y., Zhou, H., Dong, M., Larrea, E., Xue, L., Zhang, L., & Koziol, M. J. (2024). Single-cell discovery of m6A RNA modifications in the hippocampus.

Feng, S., Tellaetxe-Abete, M., Zhang, Y., Peng, Y., Zhou, H., Dong, M., Larrea, E., Xue, L., Zhang, L., & Koziol, M. J. (2023, December 13). Single-cell discovery of m6A RNA modifications in the hippocampus.

Wen, M.-H., Triana, H. B., Butler, R., Hu, H.-W., Dai, Y.-H., Lawrence, N., Hong, J.-J., Garrett, N., Jones-Green, R., Rawlins, E. L., & others. (2023). Deterministic nuclear reprogramming of mammalian nuclei to a totipotency-like state by amphibian meiotic oocytes for stem cell therapy in humans.